Vivos (RDGL) Receivables - Other (2010 - 2017)
Vivos recorded quarterly Receivables - Other of $137000.0 in Q4 2017, little changed quarter-over-quarter from $137000.0 in Q3 2017, and up 7.42% year-over-year from $127533.0 in Q4 2016.
Vivos' Receivables - Other history runs 4 years deep, the most recent figure standing at $137000.0 for Q4 2017.
- In Q4 2017, Receivables - Other rose 7.42% year-over-year to $137000.0; the TTM figure through Dec 2017 stood at $137000.0 (up 7.42% YoY), while the FY2017 annual figure was $137000.0, up 7.42% from the prior year.
- Receivables - Other came in at $137000.0 for Q4 2017 at Vivos, roughly flat from $137000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $137000.0 in Q1 2017 to a low of $127533.0 in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 137,000.00 |
| Dec 31, 2017 | 137,000.00 |
| Sep 30, 2017 | 137,000.00 |
| Sep 30, 2017 | 137,000.00 |
| Jun 30, 2017 | 137,000.00 |
| Jun 30, 2017 | 137,000.00 |
| Mar 31, 2017 | 137,000.00 |
| Mar 31, 2017 | 137,000.00 |
| Dec 31, 2016 | 127,533.00 |
| Dec 31, 2016 | 127,533.00 |
| Jun 30, 2011 | 125,000.00 |
| Jun 30, 2011 | 125,000.00 |
| Dec 31, 2010 | 425,504.00 |
| Dec 31, 2010 | 425,504.00 |